APA (7th ed.) Citation

L, J., APS, M., A, W., PK, A., G, B., D, B., . . . SN, F. (2025). Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial. The Journal of infection, 91(3), 106576. https://doi.org/10.1016/j.jinf.2025.106576

Chicago Style (17th ed.) Citation

L, Janani, et al. "Heterologous COVID-19 Vaccine Schedule with Protein-based Prime (NVX-CoV2373) and MRNA Boost (BNT162b2) Induces Strong Humoral Responses: Results from COV-BOOST Trial." The Journal of Infection 91, no. 3 (2025): 106576. https://doi.org/10.1016/j.jinf.2025.106576.

MLA (9th ed.) Citation

L, Janani, et al. "Heterologous COVID-19 Vaccine Schedule with Protein-based Prime (NVX-CoV2373) and MRNA Boost (BNT162b2) Induces Strong Humoral Responses: Results from COV-BOOST Trial." The Journal of Infection, vol. 91, no. 3, 2025, p. 106576, https://doi.org/10.1016/j.jinf.2025.106576.